38848 Federal Register / Vol. 63, No. 138 / Monday, July 20, 1998 / Notices

1001 G Street, NW, Washington, D.C.

20530.

Dated: July 13, 1998.

Robert B. Briggs,

Department Clearance Officer, United States

Department of Justice.

[FR Doc. 98–19163 Filed 7–17–98; 8:45 am]

BILLING CODE 4410–01–M

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Agency Information Collection

Activities: Proposed Collection;

Comment Request

ACTION: Notice of Information Collection

Under Review; Extension of a currently

approved collection; ARCOS

Transaction Reporting—DEA Form 333.

This proposed information collection

is published to obtain comments from

the public and affected agencies.

Comments are encouraged and will be

accepted until September 18, 1998.

Request written comments and

suggestions from the public and affected

agencies concerning the proposed

collection of information.

Your comments should address one or

more of the following four points:

1. Evaluate whether the proposed

collection of information is necessary

for the proper performance of the

functions of the agency/component,

including whether the information will

have practical utility;

2. Evaluate the accuracy of the

agencies/components estimate of the

burden of the proposed collection of

information including the validity of the

methodology and assumptions used;

3. Enhance the quality, utility, and

clarity of the information to be

collected; and

4. Minimize the burden of the

collection of information on those who

are to respond, including through the

use of appropriate automated,

electronic, mechanical, or other

technological collection techniques or

other forms of information technology,

e.g., permitting electronic submission of

responses.

If you have comments, suggestions, or

need a copy of the proposed information

collection instrument with instructions,

if applicable, or additional information,

please contact Patricia Good, 202–307–

7297, Chief, Policy and Liaison Section,

Office of Diversion Control, Drug

Enforcement Administration,

Washington, DC 20537.

Overview of This Information

(1) Type of information collection:

Extension of a currently approved

collection.

(2) The title of the form/collection:

ARCOS Transaction Reporting—DEA

Form 333.

(3) The agency form number, if any,

and the applicable component of the

Department sponsoring the collection:

Form No.: DEA Form 333.

Applicable component of the

Department sponsoring the collection:

Office of Diversion Control, Drug

Enforcement Administration, U.S.

Department of Justice.

(4) Affected public who will be asked

or required to respond, as well as a brief

abstract:

Primary: Business or other for-profit.

Other: None.

Abstract: Necessary for U.S. to meet

obligations under two international

treaties: Single Convention on Narcotic

Drugs and Psychotropic Substances.

Treaties require information on the

manufacture and consumption of

certain substances. Information tracks

substances from manufacture to sale to

dispensing level.

(5) An estimate of the total number of

respondents and the amount of time

estimated for an average respondent to

respond/reply: 617 respondents. 4

responses per year × 60 minutes per

response = 4 hrs.

(6) An estimate of the total public

burden (in hours) associated with the

collection: 2,468 annual burden hours.

617 respondents × 4 hrs. per respondent

per year.

If Additional Information is Required

Contact

Mr. Robert B. Briggs, Clearance

Officer, United States Department of

Justice, Information Management and

Security Staff, Justice Management

Division, Suite 850, Washington Center,

1001 G Street, NW., Washington, DC

20530.

Dated: July 13, 1998.

Robert B. Briggs,

Department Clearance Officer, United States

Department of Justice.

[FR Doc. 98–19164 Filed 7–17–98; 8:45 am]

BILLING CODE 4410–09–M

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Agency Information Collection

Activities: Proposed Collection;

Comment Request

ACTION: Notice of Information Collection

Under Review; Extension of a currently

approved collection; Application for

Permit to Export Controlled

Substances—DEA Form 161.

This proposed information collection

is published to obtain comments from

the public and affected agencies.

Comments are encouraged and will be

accepted until September 18, 1998.

Request written comments and

suggestions from the public and affected

agencies concerning the proposed

collection of information.

Your comments should address one or

more of the following four points:

1. Evaluate whether the proposed

collection of information is necessary

for the proper performance of the

functions of the agency/component,

including whether the information will

have practical utility;

2. Evaluate the accuracy of the

agencies/components estimate of the

burden of the proposed collection of

information including the validity of the

methodology and assumptions used;

3. Enhance the quality, utility, and

clarity of the information to be

collected; and

4. Minimize the burden of the

collection of information on these who

are to respond, including through the

use of appropriate automated,

electronic, mechanical, or other

technological collection techniques or

other forms of information technology,

e.g., permitting electronic submission of

responses.

If you have comments, suggestions, or

need a copy of the proposed information

collection instrument with instructions,

if applicable, or additional information,

please contact Patricia Good, 202–307–

7297, Chief, Policy and Liaison Section,

Office of Diversion Control, Drug

Enforcement Administration,

Washington, DC 20537.

Overview of this information:

(1) Type of information collection:

Extension of a currently approved

collection.

(2) The title of the form/collection:

Application for Permit to Export

Controlled Substances—DEA Form 161.

(3) The agency form number, if any,

and the applicable component of the

Department sponsoring the collection:

Form No.: DEA Form 161.

Applicable component of the

Department sponsoring the collection:

Office of Diversion Control, Drug

Enforcement Administration, U.S.

Department of Justice.

(4) Affected public who will be asked

or required to respond, as well as a brief

abstract:

Primary: Business or other for-profit.

Other: None.

Abstract: Title 21 CFR Section

1312.22 requires individuals who export